Chui Fung Chong

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Shutian Zhang, Ning Dai, Guijun Fei et al. · Gut · 2019 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis

Barbara Klughammer, Luca Piali, Alexandra Nica et al. · Clinical and Translational Medicine · 2023 · 55 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating <scp><i>Helicobacter pylori</i></scp> in Asian patients

Xiaohua Hou, Fandong Meng, Jiangbin Wang et al. · Journal of Gastroenterology and Hepatology · 2022 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia

Aurélien Jamotte, Chui Fung Chong, Andrew Manton et al. · BMC Public Health · 2016 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐esophageal reflux disease and partial response to a healing dose of a proton‐pump inhibitor

Jan Tack, Borislav Vladimirov, Ivo Horný et al. · Neurogastroenterology & Motility · 2022 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17